BRCA-MUTATED

Clinical trials for BRCA-MUTATED explained in plain language.

Never miss a new study

Get alerted when new BRCA-MUTATED trials appear

Sign up with your email to follow new studies for BRCA-MUTATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for tough prostate cancers: adding carboplatin may slow disease

Disease control Not yet recruiting

This study tests whether adding the chemotherapy drug carboplatin to standard treatment can help men with a fast-growing type of prostate cancer that has spread. The cancer must have a BRCA gene mutation or show neuroendocrine features. About 330 men will receive either standard …

Matched conditions: BRCA-MUTATED

Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated May 26, 2026 11:19 UTC

BRCA-MUTATED

Get alerted when new BRCA-MUTATED trials appear

New hope for tough prostate cancers: adding carboplatin may slow disease